Dr. William J. Burlingham
University of Wisconsin Medical School, Madison, USA
|
Delayed Type Hypersensitivity (DTH) Status and MMF Monotherapy
|
Dr. Christiane Ferran
Beth Israel Deaconess Medical Center, Boston, USA
|
Protective Effect of A20 against Transplant-Associated Vasculopathy
|
Prof. Edward K. Geissler
University of Regensburg, Regensburg, Germany
|
Paclitaxel and Rapamycin: A One-Two Punch Against Rejection and Cancer in Organ Transplantation
|
Dr. David A. Gerber
University of North Carolina, Chapel Hill, USA
|
The Immunologic Basis of Hepatic Progenitor Cell Transplantation
|
Prof. Michel Goldman
Université Libre de Bruxelles, Bruxelles, Belgium
|
Dendritic Cells Transduced with the FasL Gene as a Tool to Regulate Allograft Immunity
|
Dr. Michael D. Gunn
Duke University Medical Center, Durham, USA
|
The Role of Plasmacytoid Dendritic Cells in the Development of Tolerance
|
Dr. Anatolij Horuzsko
Medical College of Georgia, Augusta, USA
|
Prevention of Skin Allograft Rejection by HLA-G-Modified Dendritic Cells
|
Prof. Ian Hutchinson
University of Manchester, Manchester, UK
|
VEGF: A Central Mediator in both Acute and Chronic Transplant Rejection
|
Dr. Koichi Shimizu
Brigham & Women's Hospital, Boston, USA
|
Source of Intimal Smooth Muscle like Cells in Aortic Allograft Arteriopathy
|
Dr. Thomas Wekerle
Vienna General Hospital, Vienna, Austria
|
Tolerance through Hematopoietic Cell Transplantation with Costimulation Blockade
|
